Acute psychosis after administration of bupropion hydrochloride (Zyban®);Akute Psychose nach Gabe von Bupropionhydrochlorid (Zyban®)

Psychiatrische Praxis, Supplement

Volumn 31, Issue 1, 2004, Pages

  Neumann, Marcus ^a,b   Livak, Vitali ^a   Paul, Hans Werner ^a  

^a Bezirksklinikum Gabersee   (Germany)

^b Bezirksklinikum Gabersee   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ACUTE PSYCHOSIS; ADULT; CANNABIS ADDICTION; CASE REPORT; CONFERENCE PAPER; HOSPITAL ADMISSION; HUMAN; PRESCRIPTION; SCHIZOPHRENIFORM DISORDER; WITHDRAWAL SYNDROME;

EID: 11144288151     PISSN: 16118332     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-828457     Document Type: Conference Paper

References (5)

1. th ed. Montvale: Medical Economics Company, 1999: 400-407
2. Grohmann R, Rüther E, Engel RR, Hippius H. Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiatry 1999; 32: 21-28
3. Hurt RD, Sachs DPL, Glover ED et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-1202
4. Johnston JA, Lineberry CG, Ascher JA et al. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 1991; 52: 450-456
5. Jorenby DE, Leischow SJ, Nides MA et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-691